CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

被引:68
作者
Bechter, OE [1 ]
Eisterer, W [1 ]
Dlaska, M [1 ]
Kühr, T [1 ]
Thaler, J [1 ]
机构
[1] Univ Innsbruck Hosp, Dept Gen Internal Med, A-6020 Innsbruck, Austria
关键词
D O I
10.1016/S0301-472X(01)00760-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Expression of the catalytic subunit of the telomerase enzyme hTERT is essential for prolonging the replicative lifespan and is the rate-limiting step in cellular immortalization and carcinogenesis. Because hTERT expression is positively correlated with telomerase activity, its regulation is suggested as the major determinant of enzymatic activity. The hTERT promoter region contains two CpG islands, which are known to be target sites for de novo DNA methylation. To elucidate the impact of this epigenetic mechanism on telomerase activity, we analyzed the degree of hTERT promoter methylation in 30 patients with B-cell chronic lymphocytic leukemia. Materials and Methods. hTERT promoter methylation was assessed using a methylation-specific competitive polymerase chain reaction assay. The assay is based on digestion of genomic DNA with a methylation-sensitive restriction enzyme before amplification with an internal standard. Results. Patients exhibiting, high telomerase activity showed significantly less methylation of the hTERT promoter core domain than patients with low enzyme activity. In addition, telomerase activity was significantly associated with telomere length and overall survival. Conclusions. Our data show that the degree of CpG island methylation of the hTERT promoter exhibits an impact on telomerase activity in a subgroup of patients with B-cell chronic lymphocytic leukemia and therefore is assumed to play a role in regulating hTERT gene expression in these patients. (C) 2002 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:26 / 33
页数:8
相关论文
共 50 条
  • [1] HIGH-LEVELS OF DENOVO METHYLATION AND ALTERED CHROMATIN STRUCTURE AT CPG ISLANDS IN CELL-LINES
    ANTEQUERA, F
    BOYES, J
    BIRD, A
    [J]. CELL, 1990, 62 (03) : 503 - 514
  • [2] Avilion AA, 1996, CANCER RES, V56, P645
  • [3] Bechter OE, 1998, CANCER RES, V58, P4918
  • [4] CHRONIC LYMPHOCYTIC-LEUKEMIA - PROPOSALS FOR A REVISED PROGNOSTIC STAGING SYSTEM
    BINET, JL
    CATOVSKY, D
    CHANDRA, P
    DIGHIERO, G
    MONTSERRAT, E
    RAI, KR
    SAWITSKY, A
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1981, 48 (03) : 365 - 367
  • [5] STRUCTURE AND FUNCTION OF TELOMERES
    BLACKBURN, EH
    [J]. NATURE, 1991, 350 (6319) : 569 - 573
  • [6] Extension of life-span by introduction of telomerase into normal human cells
    Bodnar, AG
    Ouellette, M
    Frolkis, M
    Holt, SE
    Chiu, CP
    Morin, GB
    Harley, CB
    Shay, JW
    Lichtsteiner, S
    Wright, WE
    [J]. SCIENCE, 1998, 279 (5349) : 349 - 352
  • [7] CHESON BD, 1997, BLOOD, V12, P4990
  • [8] MATHEMATICAL CONSIDERATIONS OF COMPETITIVE POLYMERASE CHAIN-REACTION
    CONNOLLY, AR
    CLELAND, LG
    KIRKHAM, BW
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1995, 187 (02) : 201 - 211
  • [9] THE CPG DINUCLEOTIDE AND HUMAN GENETIC-DISEASE
    COOPER, DN
    YOUSSOUFIAN, H
    [J]. HUMAN GENETICS, 1988, 78 (02) : 151 - 155
  • [10] Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase
    Counter, CM
    Meyerson, M
    Eaton, EN
    Ellisen, LW
    Caddle, SD
    Haber, DA
    Weinberg, RA
    [J]. ONCOGENE, 1998, 16 (09) : 1217 - 1222